恒达科技(01725.HK)易主後股价续飙58%曾见24.9元屡创纪录高
2018年8月才以每股1.75元来港上市的内地电子制造服务(EMS)供应商--恒达科技(01725.HK),其63.75%股权易主香港航天科技集团兼提全购後,股价继昨天复牌飙升3.2倍创纪录高後,今天进一步升破昨天盘中所创高位17.5元,最高见24.9元,现造24.8元,续涨58%,成交313万股,涉资7,088万元。
香港航天科技集团主要从事卫星制造、卫星发射、航天测控及航天数据服务,弥补航天产业区域商业空白,推动航天技术市场化,服务区域航天商业化需求及投资控股。不过,要约人现时正在推进其要约人业务开发,尚未开展卫星制造业务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.